National Health Investors (NHI) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $3.49B | Exchange | NYSE |
| Sector | Real Estate | Industry | REIT - Healthcare Facilities |
| Country | US | CEO | D. Eric Mendelsohn |
| IPO Date | 1991-10-09 | CAGR | 12.05% |
| Employees | 32 | Website | www.nhireit.com |
| Div. Yield | 2.8% | Payout Ratio | 105% |
| Buy Back Yield | — | Total Yield | 2.8% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $5.04B | P/E | 20.49 | Forward P/E | 22.15 | PEG | -0.48 |
| P/S | 14.68 | P/B | 4.04 | P/CF | 25.38 | P/FCF | 26.99 |
| Sales | $433.57M | Sales 1Y | 24.35% | Sales 3Y | 41.12% | Sales 5Y | 35.17% |
| EPS | $3.51 | EPS 1Y | 10.54% | EPS 3Y | 79.94% | EPS 5Y | 1.47% |
| Sales QoQ | 4.72% | EPS QoQ | 40.24% | Sales QoQ Avg | 7.79% | EPS QoQ Avg | 11.51% |
| Gross Margin | 64.67% | Operating Margin | 45.45% | Profit Margin | 38.47% | ROCE | 8.11% |
| ROA | 6% | ROE | 11% | Altman Z Score | 1.63 | Piotroski Score | 6 |
| Current Ratio | 0.59 | Quick Ratio | 0.59 | Cash Ratio | 0.06 | Op. CF Ratio | 0.12 |
| Debt/Equity | 0.82 | Debt/Assets | 0.43 | Lt Debt/Equity | 0.54 | Lt Debt/Cap. | 0.35 |
| Intrst Cov. | 4.46 | Inventory Turnover | — | Asset Turnover | 0.15 | Receivables Turnover | 2.07 |
| Enterprise Value | $5.04B | P/E Ratio | 20.49 |
| Forward P/E | 22.15 | PEG Ratio | -0.48 |
| P/S Ratio | 14.68 | P/B Ratio | 4.04 |
| P/CF Ratio | 25.38 | P/FCF Ratio | 26.99 |
| EPS | $3.51 | EPS Growth 1Y | 10.54% |
| EPS Growth 3Y | 79.94% | EPS Growth 5Y | 1.47% |
| Revenue Growth 1Y | 24.35% | Gross Margin | 0.65% |
| Operating Margin | 0.45% | Profit Margin | 0.38% |
| ROE | 0.11% | ROA | 0.06% |
| ROCE | 0.08% | Current Ratio | 0.59 |
| Quick Ratio | 0.59 | Cash Ratio | 0.06 |
| Debt/Equity | 0.82 | Interest Coverage | 4.46 |
| Altman Z Score | 1.63 | Piotroski Score | 6 |
National Health Investors (NHI) valuation & financials
National Health Investors (NHI) has a market capitalization of $3.49B and trades at a price-to-earnings ratio of 20.5. It operates in the Real Estate sector (REIT - Healthcare Facilities).
National Health Investors's revenue grew +24.4% over the last year.
National Health Investors's next earnings report is scheduled for November 5, 2026 after market close; analysts estimate EPS of $1.32. Check the earnings calendar to see all companies reporting this week.
National Health Investors (NHI) — frequently asked questions
When does National Health Investors (NHI) report earnings next?
National Health Investors is expected to report earnings on November 5, 2026 after market close. Analysts estimate EPS of $1.32.
What is National Health Investors's market cap?
National Health Investors (NHI) has a market capitalization of $3.49B.
What is NHI's P/E ratio?
National Health Investors trades at a price-to-earnings ratio of 20.5, with trailing twelve-month EPS of $3.51.
How fast is National Health Investors growing?
National Health Investors's revenue grew +24.4% over the last year.
Compare with other Real Estate companies: Welltower (WELL) · Prologis (PLD) · Equinix (EQIX) · American Tower (AMT) · Digital Realty (DLR) · Simon Property Group (SPG)